AQUABILITI AQUASTAT 0.9% Sodium Chloride Injection syringe, USP, 5mL in 12mL, REF 2T0805; and 3mL in 12mL, REF 2T0807, intermediate cartons containing 100 syringes, shipping cases containing 400 syringes, Rx, Sterile.
Published February 28, 2024 · Recall initiated: December 28, 2023
Summary
FDA records medical device Class II recall Z-1174-2024, published February 28, 2024 and initiated December 28, 2023. Recalling firm: MRP, LLC dba Aquabiliti; Status: Ongoing; Reported quantity: 3,080,000 syringes; Lot: REF 2T0805 - Lot numbers KH04910, exp. 1/11/2024; KH04930, exp. 3/13/2024; KH04954, exp. 5/22/2024; KH04975, exp. 8/2/2024; KH04990, exp. 9/6/2024; KH05020, exp. 10/23/2024; KH05022, exp. 10/24/2024; KH05043, exp. 11/13/2024; KH05066, exp. 12/13/2024; KH05068, exp. 12/14/2024; KH05070, exp. 12/18/2024; KH05073, exp. 12/20/2024; KH05134, exp. 6/25/2025; KH05135, exp. 6/27/2025; and KH05152, exp. 10/10/2025; UDI-DI 10859809005013. REF 2T0807 - Lot numbers KH04909, exp. 1/10/2024; KH04944, exp. 4/24/2024; KH04986, exp. 8/30/2024; KH04988, exp. 9/5/2024; KH05024, exp. 10/25/2024; KH05026, exp. 10/26/2024; and KH05071, exp. 12/19/2024; UDI-DI 10859809005037. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The saline flush syringes may fail to meet USP criteria for stated sodium chloride content after 12 months.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- MRP, LLC dba Aquabiliti
- Distributor
- US Nationwide distribution in the states CO, FL, NC, NY, OH, PA, TN, TX, and VA.
- Lot
- REF 2T0805 - Lot numbers KH04910, exp. 1/11/2024; KH04930, exp. 3/13/2024; KH04954, exp. 5/22/2024; KH04975, exp. 8/2/2024; KH04990, exp. 9/6/2024; KH05020, exp. 10/23/2024; KH05022, exp. 10/24/2024; KH05043, exp. 11/13/2024; KH05066, exp. 12/13/2024; KH05068, exp. 12/14/2024; KH05070, exp. 12/18/2024; KH05073, exp. 12/20/2024; KH05134, exp. 6/25/2025; KH05135, exp. 6/27/2025; and KH05152, exp. 10/10/2025; UDI-DI 10859809005013. REF 2T0807 - Lot numbers KH04909, exp. 1/10/2024; KH04944, exp. 4/24/2024; KH04986, exp. 8/30/2024; KH04988, exp. 9/5/2024; KH05024, exp. 10/25/2024; KH05026, exp. 10/26/2024; and KH05071, exp. 12/19/2024; UDI-DI 10859809005037.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAOPTIMIZER model CCM X11 implantable pulse generator (IPG) devices - Smart Mini and LiteFebruary 28, 2024
- FDAAutomated Impella Controller (AIC), Product No. 0042-0000-US, 0042-0010-US, 0042-0040-US. Used with ImpellaFebruary 28, 2024
- FDASynapse CV 6. with AR. A web-based application as the primary user interface for the processing of medicalFebruary 28, 2024
- FDAAzurion 3 with a Certeray generator -To perform image guidance in diagnostic, interventional, and minimallyFebruary 28, 2024
- FDASynapse Cardiology PACS V7.3.0, V7.2, V7.1, V7.0. A web-based application as the primary user interface forFebruary 28, 2024
- FDAAzurion 5 with a Certeray generator-To perform image guidance in diagnostic, interventional, and minimallyFebruary 28, 2024
Questions about this recall
Was AQUABILITI AQUASTAT 0.9% Sodium Chloride Injection syringe, USP, 5mL in 12mL, REF 2T0805; and 3mL in 12mL, REF 2T0807, intermediate cartons containing 100 syringes, shipping cases containing 400 syringes, Rx, Sterile. recalled?
Yes. FDA published recall Z-1174-2024 on February 28, 2024. Reported hazard: The saline flush syringes may fail to meet USP criteria for stated sodium chloride content after 12 months.
What should I do if I have this product?
Voluntary: Firm initiated · Letter